Skip to main content
Clinical Trials/CTRI/2017/12/010845
CTRI/2017/12/010845
Recruiting
Phase 2

â??Comparative Study of Efficacy of â??Shunthyadi Churnaâ?? and â??Parnasapanchaka Kwathaâ?? in the Management of Tamaka Shwasa with special reference to Bronchial Asthmaâ??.

ational Institute of Ayurved0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
ational Institute of Ayurved
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
ational Institute of Ayurved

Eligibility Criteria

Inclusion Criteria

  • 1\.Patient willing to give informed consent to participate for 30 days.
  • 2\.Patients of either sex with age between 18 to 60 years.
  • 3\.Patient with stable Bronchial Asthma (Tamaka Shwasa) (as per WHO GINA Guideline) for at least 6 weeks prior to trial.
  • 4\.Patient presents with signs \& symptoms of Tamaka Shwasa (Bronchial Asthma) as mentioned in Ayurvedic and modern texts.
  • 5\.Symptomatic patient with positive test of reversibility (If possible).

Exclusion Criteria

  • 1\.Patients with severe Bronchial Asthma.
  • 2\.Patients present with co\-morbid disorders. (D.M., T.B., R.A., Carcinoma etc.).
  • 3\.Patients suffering from pulmonary diseases other than bronchial asthma like COPD, Pleural effusion, Pneumonia.
  • 4\.Patients with poorly controlled Hypertension (i.e. Systolic \> 160 mm of Hg and Diastolic \> 100 mm of Hg)
  • 5\.Patients with concurrent serious Hepatic disorder or Renal Disorders, severe Pulmonary Dysfunction, or any other systemic/serious complications like Cerebrovascular / Cardiovascular disease that may jeopardize the study.
  • 6\.H/o hypersensitivity to the trial drug or any of its ingredients.
  • 7\.Patients who have completed participation in any other clinical trial during the past six months.
  • 8\.Pregnancy or lactating women.
  • 9\.Any other condition which the Investigator thinks may jeopardize the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials